Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2004

Primary Completion Date

December 31, 2007

Study Completion Date

June 30, 2013

Conditions
Leukemia
Interventions
DRUG

arsenic trioxide

DRUG

cytarabine

DRUG

daunorubicin hydrochloride

DRUG

mercaptopurine

DRUG

methotrexate

DRUG

tretinoin

Trial Locations (7)

15232

Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh

21201

Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore

30342

Blood and Marrow Transplant Group of Georgia, Atlanta

35294

Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham

32610-0232

University of Florida Shands Cancer Center, Gainesville

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

68198-3330

UNMC Eppley Cancer Center at the University of Nebraska Medical Center, Omaha

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00276601 - Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia | Biotech Hunter | Biotech Hunter